Boston Research & Management Inc Eli Lilly & CO Transaction History
Boston Research & Management Inc
- $426 Million
- Q3 2024
A detailed history of Boston Research & Management Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Boston Research & Management Inc holds 4,188 shares of LLY stock, worth $3.16 Million. This represents 0.87% of its overall portfolio holdings.
Number of Shares
4,188
Previous 4,433
5.53%
Holding current value
$3.16 Million
Previous $4.01 Million
7.55%
% of portfolio
0.87%
Previous 1.01%
Shares
5 transactions
Others Institutions Holding LLY
# of Institutions
4,007Shares Held
752MCall Options Held
8.27MPut Options Held
10.5M-
Lilly Endowment Inc Indianapolis, IN96.9MShares$73.2 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA73.8MShares$55.7 Billion1.2% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$49.7 Billion1.37% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$38.8 Billion29.2% of portfolio
-
State Street Corp Boston, MA33.9MShares$25.6 Billion1.24% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $717B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...